Search
Skip to Search Results- 4Mitochondria
- 2Epoxyeicosatrienoic acids
- 1Cardiac Ischemia reperfuion injury
- 1Cardiac metabolism
- 1EETs
- 1Ischemia/Reperfusion injury
-
Mechanisms by Which Arachidonic acid Metabolite, Epoxyeicosatrienoic acid Elicit Cardioprotection Against Ischemic Reperfusion Injury
DownloadFall 2011
Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that have cardioprotective properties but the exact mechanism(s) remains unknown. Evidence suggests phosphoinositide 3-kinase (PI3K) and plasma membraneATP-sensitive potassium channels (pmKATP) are...
-
Fall 2015
Ischemic heart Disease (IHD) remains a major cause of illness and death worldwide. Therefore, therapeutic agents to protect against myocardial ischemia are needed. Arachidonic acid (AA) is metabolized by cytochrome P450 (CYP) epoxygenase into the biologically active epoxyeicosatrienoic acids...
-
Spring 2016
Mitochondria are at the center of cardiac health and disease. These vital organelles provide most of the energy to the contractile apparatus and play a strategic role in cardiomyocyte survival during cellular stress. Cardiovascular diseases and many aging related diseases are often associated...
-
The Cardioprotective Role of the N-3 PUFA Metabolite 19,20-Epoxydocosapentaenoic Acid (19,20-EDP) in the Setting of Ischemia Reperfusion Injury
DownloadSpring 2022
Ischemic heart disease (IHD) is a leading cause of cardiovascular morbidity and mortality worldwide. Myocardial ischemia occurs when a coronary artery is occluded and consequently blood supply to the heart is restricted depleting it of oxygen and nutrients. Although early myocardial reperfusion,...